ciclosporin-aminoacid derivative (Lipicard)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameciclosporin-aminoacid derivative (Lipicard)
Drug Alias NameKeraKlear
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCalcineurin inhibitors
TargetsCalcineurin
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipicard Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipicard Technologies
Active IndicationsN/A
Inactive IndicationsXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A